Shuhei Nishiguchi

15.7k total citations · 5 hit papers
314 papers, 9.3k citations indexed

About

Shuhei Nishiguchi is a scholar working on Hepatology, Epidemiology and Physiology. According to data from OpenAlex, Shuhei Nishiguchi has authored 314 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 207 papers in Hepatology, 188 papers in Epidemiology and 63 papers in Physiology. Recurrent topics in Shuhei Nishiguchi's work include Liver Disease Diagnosis and Treatment (163 papers), Hepatitis C virus research (91 papers) and Liver Disease and Transplantation (75 papers). Shuhei Nishiguchi is often cited by papers focused on Liver Disease Diagnosis and Treatment (163 papers), Hepatitis C virus research (91 papers) and Liver Disease and Transplantation (75 papers). Shuhei Nishiguchi collaborates with scholars based in Japan, United States and China. Shuhei Nishiguchi's co-authors include Hiroki Nishikawa, Tetsuo Kuroki, Akihiro Tamori, Hirayuki Enomoto, Susumu Shiomi, Shoji Kubo, Hiroko Iijima, Osamu Yokosuka, Masao Omata and Kazuhide Higuchi and has published in prestigious journals such as JAMA, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Shuhei Nishiguchi

305 papers receiving 9.1k citations

Hit Papers

Interferon Therapy Reduce... 1999 2026 2008 2017 1999 2000 2016 2021 2021 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan
    1999 854 citations Haruhiko Yoshida, Yasushi Shiratori et al. profile →
  2. Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy
    2000 573 citations Yasushi Shiratori, Michitami Yano et al. profile →
  3. Japan Society of Hepatology guidelines for sarcopenia in liver disease (1st edition): Recommendation from the working group for creation of sarcopenia assessment criteria
    2016 474 citations Hiroki Nishikawa, Shuhei Nishiguchi et al. Hepatology Research profile →
  4. Metabolic Syndrome and Sarcopenia
    2021 190 citations Hiroki Nishikawa, Akira Asai et al. profile →
  5. Cancer Cachexia: Its Mechanism and Clinical Significance
    2021 149 citations Hiroki Nishikawa, Masahiro Goto et al. International Journal of Molecular Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shuhei Nishiguchi Japan 44 5.4k 5.3k 1.9k 1.2k 1.1k 314 9.3k
Misael Uribe Mexico 45 4.5k 0.8× 3.2k 0.6× 876 0.5× 960 0.8× 2.1k 1.9× 328 7.8k
Takumi Kawaguchi Japan 45 4.2k 0.8× 2.9k 0.6× 1.2k 0.6× 2.2k 1.9× 1.6k 1.5× 290 8.4k
Masahide Hamaguchi Japan 41 4.0k 0.7× 1.2k 0.2× 1.8k 0.9× 1.1k 0.9× 879 0.8× 280 8.1k
Salvatore Petta Italy 61 9.4k 1.7× 5.6k 1.1× 1.1k 0.6× 894 0.8× 1.5k 1.3× 256 11.2k
Henning Grønbæk Denmark 43 5.2k 1.0× 2.3k 0.4× 745 0.4× 1.3k 1.1× 1.6k 1.4× 329 8.4k
Agustı́n Albillos Spain 57 7.7k 1.4× 7.6k 1.4× 1.1k 0.6× 1.7k 1.4× 4.0k 3.6× 269 11.8k
Han‐Chieh Lin Taiwan 53 6.6k 1.2× 7.6k 1.4× 806 0.4× 842 0.7× 3.7k 3.4× 456 11.7k
Flemming Bendtsen Denmark 53 8.0k 1.5× 6.5k 1.2× 693 0.4× 1.2k 1.0× 4.1k 3.8× 340 12.1k
Masanori Abe Japan 43 3.1k 0.6× 2.4k 0.5× 559 0.3× 751 0.6× 995 0.9× 307 6.3k
Manal F. Abdelmalek United States 64 13.3k 2.5× 5.8k 1.1× 2.3k 1.2× 3.0k 2.5× 2.4k 2.2× 207 16.9k

Countries citing papers authored by Shuhei Nishiguchi

Since Specialization
Citations

This map shows the geographic impact of Shuhei Nishiguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuhei Nishiguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuhei Nishiguchi more than expected).

Fields of papers citing papers by Shuhei Nishiguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuhei Nishiguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuhei Nishiguchi. The network helps show where Shuhei Nishiguchi may publish in the future.

Co-authorship network of co-authors of Shuhei Nishiguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Shuhei Nishiguchi. A scholar is included among the top collaborators of Shuhei Nishiguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuhei Nishiguchi. Shuhei Nishiguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Itakura, Jun, Masayuki Kurosaki, Hiroko Setoyama, et al.. (2021). Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis. Journal of Gastroenterology. 56(5). 470–478. 32 indexed citations
2.
Nishikawa, Hiroki, Masahiro Goto, Shinya Fukunishi, et al.. (2021). Cancer Cachexia: Its Mechanism and Clinical Significance. International Journal of Molecular Sciences. 22(16). 8491–8491. 149 indexed citations breakdown →
3.
Yoh, Kazunori, Hiroki Nishikawa, Hirayuki Enomoto, et al.. (2018). Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial. BMJ Open Gastroenterology. 5(1). e000194–e000194. 10 indexed citations
4.
5.
Takashima, Tomoyuki, Hirayuki Enomoto, Yoshinori Iwata, et al.. (2016). Effects of Helicobacter pylori Eradication on the Platelet Count in Hepatitis C Virus-Infected Patients. Journal of Clinical Medicine Research. 8(12). 854–858. 5 indexed citations
6.
Enomoto, Masaru, Shuhei Nishiguchi, Akihiro Tamori, et al.. (2015). Long-Term Outcome of Sequential Therapy with Lamivudine Followed by Interferon-β in Nucleoside-Naive, Hepatitis B e-Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection. Journal of Interferon & Cytokine Research. 35(8). 613–620. 5 indexed citations
7.
Enomoto, Hirayuki, Shinichi Inoue, Akio Matsuhisa, & Shuhei Nishiguchi. (2014). Diagnosis of Spontaneous Bacterial Peritonitis and anIn SituHybridization Approach to Detect an “Unidentified” Pathogen. International Journal of Hepatology. 2014. 1–7. 16 indexed citations
8.
Enomoto, Hirayuki, Nobuhiro Aizawa, Hideji Nakamura, et al.. (2014). An Increased Ratio of Glycated Albumin to HbA1c Is Associated with the Degree of Liver Fibrosis in Hepatitis B Virus-Positive Patients. Gastroenterology Research and Practice. 2014. 1–6. 10 indexed citations
9.
Nishiguchi, Shuhei. (2014). Comparison of each HBs antigen assay and it^|^apos;s clinical utility. Kanzo. 55(6). 310–324.
10.
Enomoto, Hirayuki, Shuhei Nishiguchi, Nobuhiro Aizawa, et al.. (2014). Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis. Journal of Clinical Biochemistry and Nutrition. 55(2). 147–152. 27 indexed citations
11.
Tanaka, Hironori, Hiroko Iijima, Kazunori Yoh, et al.. (2013). New malignant grading system for hepatocellular carcinoma using the Sonazoid contrast agent for ultrasonography. Journal of Gastroenterology. 49(4). 755–763. 35 indexed citations
12.
Suzuki, Kazuyuki, Kazuyuki Suzuki, Ryujin Endo, et al.. (2012). Guidelines on nutritional management in Japanese patients with liver cirrhosis from the perspective of preventing hepatocellular carcinoma. Hepatology Research. 42(7). 621–626. 32 indexed citations
13.
Noguchi, Tohru, Akihiro Tamori, Naoki Ogura, et al.. (2011). Investigation of Interferon-α Response by a Single Amino Acid Substitution of Nonstructural Protein 5A in Hepatitis C Virus-Infected Patients. Journal of Interferon & Cytokine Research. 31(8). 589–599. 2 indexed citations
14.
Enomoto, Masaru, Akihiro Tamori, Takehiro Hayashi, et al.. (2007). Lamivudine and IFN- β Sequential Therapy in HBe Antigen-Positive Patients with Chronic Hepatitis B Virus Genotype C Infection. Journal of Interferon & Cytokine Research. 27(3). 201–208. 7 indexed citations
15.
Uenishi, Takahiro, Osamu Yamazaki, Hiromu Tanaka, et al.. (2007). Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 15(2). 583–589. 70 indexed citations
16.
Nishiguchi, Shuhei, Motoharu Tanaka, Masaru Enomoto, et al.. (2003). Association of HLA Alleles with Response (Especially Biochemical Response) to Interferon Therapy in Japanese Patients with Chronic Hepatitis C. Journal of Interferon & Cytokine Research. 23(3). 135–141. 5 indexed citations
17.
Enomoto, Masaru, Shuhei Nishiguchi, Motoharu Tanaka, et al.. (2002). Dynamics of Hepatitis C Virus Monitored by Real-Time Quantitative Polymerase Chain Reaction During First 2 Weeks of IFN- β Treatment Are Predictive of Long-Term Therapeutic Response. Journal of Interferon & Cytokine Research. 22(3). 389–395. 6 indexed citations
18.
Yoshida, Haruhiko, Yasuyuki Arakawa, Michio Sata, et al.. (2002). Interferon therapy prolonged life expectancy among chronic hepatitis C patients. Gastroenterology. 123(2). 483–491. 194 indexed citations
19.
Nishiguchi, Shuhei, Susumu Shiomi, Nobumitsu Sasaki, et al.. (2000). Course before and after percutaneous transhepatic portal vein embolization of a patient with cholangiocarcinoma monitored by scintigraphy with Tc-99m galactosyl human serum albumin. Annals of Nuclear Medicine. 14(3). 231–234. 4 indexed citations
20.
Kubo, Shoji, Shuhei Nishiguchi, Tetsuo Kuroki, et al.. (1997). Poor association of GBV-C viremia with hepatocellular carcinoma. Journal of Hepatology. 27(1). 91–95. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Misael Uribe Breakdown of academic impact, for papers by Takumi Kawaguchi Breakdown of academic impact, for papers by Masahide Hamaguchi Breakdown of academic impact, for papers by Salvatore Petta Breakdown of academic impact, for papers by Henning Grønbæk Breakdown of academic impact, for papers by Agustı́n Albillos Breakdown of academic impact, for papers by Han‐Chieh Lin Breakdown of academic impact, for papers by Flemming Bendtsen Breakdown of academic impact, for papers by Masanori Abe Breakdown of academic impact, for papers by Manal F. Abdelmalek
Rankless by CCL
2026